PharmiWeb.com - Global Pharma News & Resources
10-Jul-2019

In Vitro Diagnostics Market Size Poised to Touch USD 99 Billion by 2026

The global In Vitro Diagnostics Market Size projected to register USD 99 billion by 2026, registering at a CAGR growth of 7.1% over the forecast period

Growing geriatric populace, which is prone to many diseases and in need of regular diagnostic tests, is one of the main drivers for this industry. Also, increasing occurrence cardiovascular disorders, diabetes, cancer, and other chronic illnesses paired with growing need for onsite diagnostics is anticipated to further push the in vitro diagnostics (IVD) industry.

As indicated by the American Cancer Society (ACS), about 1.7 million new cancer growth cases are evaluated to be accounted for in 2018 and around 609,640 people are probably going to die because of cancer disease in 2018. Most regular kinds of cancer are colorectal, breast, stomach, lung, and liver. In addition, the number of cancer cases is relied upon to increment by around 70% throughout the following two decades. Unhealthy dietary habits, sedentary lifestyle, high tobacco and liquor utilization, and obesity are the elements expected to add to predominance of cancer.

Developing utilization of Fluorescence In Situ Hybridization (FISH) and Enzyme Linked Immunosorbent Assay (ELISA) advancements is additionally foreseen to support showcase development amid the estimate time frame. continous Ramp;D to acquaint improved advances are normal with push the market. For example, in November 2017, illumina, Inc., reported the presentation of NextSeq 550Dx instrument, which is relied upon to convey high-throughput Next-Generation Sequencing (NGS) to clinical research centers. The presentation of Xpert measure for tuberculosis testing by Cepheid on its GeneXpert stage is another case of a headway. Such progressions are foreseen to drive the worldwide IVD showcase.

Some of the key players in the in vitro diagnostics market are bioMerieux SA, Dickinson and Company, F. Hoffmann-La Roche Ltd., Hologic, Inc. (Gen-Probe), Siemens Healthineers, Becton, and others. These players are occupied with embracing activities, for example, new item improvement, joint efforts, mergers and procurement to build their share of the overall industry and item portfolio. For example, in September 2018, Ortho Clinical Diagnostics presented VITROS Anti-T. cruzi measure with CE check endorsement in Mexico. What's more, in June 2017, Ortho Clinical Diagnostics propelled VITROS NephroCheck test, a hazard appraisal apparatus for anticipating Acute Kidney Injury, with CE Mark freedom from European Commission.

Download Free Sample Report Pages at https://www.acumenresearchandconsulting.com/request-sample/988

The global minimally in vitro diagnostics market is segmented into product, technology, end-user, application, and region. On the basis of product, the global minimally in vitro diagnostics market is segmented into instruments, reagents, and services. On the basis of end-user, the global minimally in vitro diagnostics market is segmented into hospital, laboratory, home care, and others. On the basis of application, the global minimally in vitro diagnostics market is segmented into Infectious disease, diabetes, oncology, cardiology, nephrology, autoimmune diseases, drug testing and others. On the basis of technology, the global minimally in vitro diagnostics market is segmented into immunology, hematology, clinical chemistry, molecular diagnostics, coagulation, microbiology, and others. On the basis of region the global minimally in vitro diagnostics market is segmented into Latin America, Europe, Asia Pacific, North America, and Middle East amp; Africa.

North America held the largest market share of 47.44% in 2018. Favourable government regulations,, high healthcare spending, and nearness of key market players are the key factors accountable for the regional development.

Also again, Asia Pacific is anticipated to observer the fastest development over the forecast period. It is foreseen to extend at a CAGR of 8.01% over the forecast period. High neglected clinical necessities, enhancing human services framework, and high target populace are foreseen to give development potential to enter producers in the district.

Based on end use, the market is sectioned into hospitals, laboratories, home care, and others. IVD service are utilized by hospitals and laboratories and research centers and additionally straightforwardly by patients. Hospitals represented the biggest piece of the pie of 46.01% in 2017, attributable to appeal because of ascend in hospitalization. Homecare portion, then again, is required to enroll the quickest CAGR of 8.48% over the gauge time frame.

View Detail Information at https://www.acumenresearchandconsulting.com/in-vitro-diagnostics-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of In Vitro Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. In Vitro Diagnostics Market By Product
1.2.2.1. Global In Vitro Diagnostics Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global In Vitro Diagnostics Market Revenue Share By Product in 2017
1.2.2.3. Instruments
1.2.2.4. Reagents
1.2.2.5. Services
1.2.2.6. Others
1.2.3. In Vitro Diagnostics Market By Technology
1.2.3.1. Global In Vitro Diagnostics Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Global In Vitro Diagnostics Market Revenue Share By Technology in 2017
1.2.3.3. Immunology
1.2.3.4. Hematology
1.2.3.5. Clinical chemistry
1.2.3.6. Molecular Diagnostics
1.2.3.7. Coagulation
1.2.3.8. Microbiology
1.2.3.9. Others
1.2.4. In Vitro Diagnostics Market By Application
1.2.4.1. Global In Vitro Diagnostics Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Global In Vitro Diagnostics Market Revenue Share By Application in 2017
1.2.4.3. Infectious disease
1.2.4.4. Diabetes
1.2.4.5. Oncology
1.2.4.6. Cardiology
1.2.4.7. Nephrology
1.2.4.8. Autoimmune diseases
1.2.4.9. Drug testing
1.2.4.10. Others
1.2.5. In Vitro Diagnostics Market By End Users
1.2.5.1. Global In Vitro Diagnostics Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.5.2. Global In Vitro Diagnostics Market Revenue Share By End Users in 2017
1.2.5.3. Hospital
1.2.5.4. Laboratory
1.2.5.5. Home care
1.2.5.6. Others
1.2.6. In Vitro Diagnostics Market by Geography
1.2.6.1. Global In Vitro Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America In Vitro Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe In Vitro Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific In Vitro Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America In Vitro Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) In Vitro Diagnostics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global In Vitro Diagnostics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global In Vitro Diagnostics Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global In Vitro Diagnostics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global In Vitro Diagnostics Major Manufacturers in 2017

CHAPTER 4. In Vitro Diagnostics MARKET BY PRODUCT

4.1. Global In Vitro Diagnostics Revenue By Product
4.2. Instruments
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Reagents
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Services
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. In Vitro Diagnostics MARKET By Technology

5.1. Global In Vitro Diagnostics Revenue By Technology
5.2. Immunology
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Hematology
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Clinical chemistry
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Molecular Diagnostics
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Coagulation
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Microbiology
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. Others
5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. In Vitro Diagnostics MARKET By Application

6.1. Global In Vitro Diagnostics Revenue By Application
6.2. Infectious disease
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Diabetes
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Oncology
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Cardiology
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Nephrology
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Autoimmune diseases
6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.8. Drug testing
6.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.9. Others
6.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. In Vitro Diagnostics MARKET By End Users

7.1. Global In Vitro Diagnostics Revenue By End Users
7.2. Hospital
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Laboratory
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Home care
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Others
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. NORTH AMERICA In Vitro Diagnostics MARKET BY COUNTRY

8.1. North America In Vitro Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America In Vitro Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. U.S.
8.3.1. U.S. In Vitro Diagnostics Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 9. EUROPE In Vitro Diagnostics MARKET BY COUNTRY

9.1. Europe In Vitro Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe In Vitro Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 10. ASIA-PACIFIC In Vitro Diagnostics MARKET BY COUNTRY

10.1. Asia-Pacific In Vitro Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific In Vitro Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 11. LATIN AMERICA In Vitro Diagnostics MARKET BY COUNTRY

11.1. Latin America In Vitro Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America In Vitro Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 12. MIDDLE EAST In Vitro Diagnostics MARKET BY COUNTRY

12.1. Middle East In Vitro Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East In Vitro Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 13. AFRICA In Vitro Diagnostics MARKET BY COUNTRY

13.1. Africa In Vitro Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Africa In Vitro Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 14. COMPANY PROFILE

14.1. bioMerieux SA
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. Dickinson and Company
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. F. Hoffmann-La Roche Ltd.
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. Hologic, Inc. (Gen-Probe)
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Siemens Healthineers
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Becton
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Others
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies

CHAPTER 15. RESEARCH APPROACH

15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope

Request for Customization at https://www.acumenresearchandconsulting.com/request-customization/988

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/988

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 10-Jul-2019